Overview

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of the ACE inhibitor ramipril in the treatment of early IgA nephropathy.
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Antibodies
Immunoglobulin A
Immunoglobulins
Ramipril